Infusion Pump Market Eyes a Milestone of US$ 821.4 Million by 2033

Comments · 31 Views

The market's ascent highlights the increasing demand for reliable and accurate infusion technologies across healthcare facilities.

The infusion pump market is expected to reach US$ 641.7 million by 2023, putting it on the verge of a significant valuation. The expansion is principally propelled by the growing awareness and understanding of the infusion pump industry. As the trend is expected to grow at a predicted CAGR of 2.5% from 2023 to 2033, new possibilities within the market are expected to arise. The market is expected to surge to a total estimated valuation of approximately US$ 821.4 million by 2033.

The global infusion pump market is experiencing remarkable growth, driven by several key factors reshaping the healthcare landscape. One of the primary drivers of this expansion is the growing prevalence of chronic diseases, including diabetes, cancer, and gastroenterological problems. These conditions require long-term care, and as a result, there is an increasing demand for home-based infusion therapies, which offer a cost-effective and convenient alternative to hospital-based treatments.

Unlock Peak Performance - Get Your Sample Now: 
https://www.futuremarketinsights.com/reports/sample/rep-gb-859

The rising number of people with such chronic illnesses has fueled the development of new products designed for home-based infusion therapies. The growing geriatric population, which often requires long-term care, has further contributed to the demand for these specialized infusion products.

The healthcare sector plays a pivotal role in propelling the infusion pump market forward. The need for precise and continuous medication delivery for managing chronic diseases has made infusion pumps indispensable in healthcare settings.

The market growth is also accelerated by advancements in drug delivery technologies, which have created infusion pumps with specific features to cater to different medical requirements.

Enteral feeding pumps provide essential nutrients, insulin pumps deliver insulin, and patient-controlled analgesia pumps offer pain relief. These pumps can administer fluids through various routes, including intravenous, subcutaneous, and arterial, ensuring therapeutic efficacy and precise fluid delivery. The shift from manual flow control methods to automated infusion pumps enhances patient care, reduces the risk of errors, and improves the overall healthcare experience.

The infusion pump market is expanding into new sectors, such as the defense industry, where there is a substantial demand for infusion systems. The application diversification thus underscores infusion pumps versatility and increasing importance in various fields.

Key Takeaways:

  • The market valuation in 2022 was US$ 626 million.
  • The market valuation in 2017 was US$ 543 million.
  • Based on product type, volumetric pumps are expected to dominate at a value share of 22% in 2023.
  • India is estimated to register at a CAGR of 3.8% by 2033.
  • China experiences significant growth, projected at a CAGR of 3.3% by 2033.

Competitive Landscape:

The infusion pump industry boasts a substantial array of market participants. Research and development play a pivotal role among these players, primarily focusing on introducing eco-friendly product lines as a core aspect of their manufacturing endeavors. Furthermore, they employ various expansion strategies, including collaborations, mergers and acquisitions, and diligent exploration of regulatory approvals to bolster their market presence.

Some of the key developments are:

  • Voluntis, a prominent player in the healthcare software industry, joined forces with Biocon biologics to revolutionize diabetes management. The strategic partnership aims to develop and offer innovative digital therapeutics designed to support diabetes patients who rely on biologics therapy.
  • Mindray Medical expanded its product portfolio by introducing the BeneFusion e series. The new line includes eSP, eVP, and eDS infusion systems, representing a technological step forward. The introduction of these advanced infusion systems reflects Mindray Medical's commitment to providing cutting-edge medical equipment to healthcare facilities.

Key Segmentation:

By Product Type:

  • Syringe Pumps
  • Ambulatory Pumps
  • Volumetric Pumps
  • Peristaltic
  • Cassette/Piston
  • Implantable Pumps
  • Insulin Pumps
  • Enteral Pumps
  • PCA Pumps
  • Pump Accessories

By Application:

  • Chemotherapy/Oncology
  • Pediatrics/Neonatology
  • Analgesia
  • Gastroenterology
  • Hematology
  • Diabetes

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care
  • Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

 

Comments